112949 ⎘
Oligonucleotides characterized by their use Screening for pharmacological compounds
Compositions and methods for treating and diagnosing cancer
#3002PRO1298 polypeptides
#3003Parkinson's disease-related disease compositions and methods
#3004Methods and compositions for diagnosis, monitoring and development of therapeutics for treatment of atherosclerotic disease
#3005Gene markers of tumor metastasis
#3006Compositions and methods for diagnosing and treating cancers
#3007Method for diagnosing chronic myeloid leukemia
#3008Hematopoietic progenitor kinase 1 for modulation of an immune response
#3009Epidermal growth factor receptor gene copy number
#3010Polynucleotide and polypeptide fat metabolism regulators and uses thereof
#3011Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710
#3012Assay and method for diagnosing and treating alzheimer's disease
#3013Gene variants and use thereof
#3014Regulation of tgf-beta signaling by tomoregulin
#3015Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480, 20893, 33230, 1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules
#3016Snail, a new marker for tumour invasion and target protein of new antitumoral compounds
#3017Schizophrenia related gene
#3018Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
#3019ERCC2 polymorphisms
#3020Gamma secretase notch biomarkers
#3021Tumor suppressor Killin
#3022XAF genes and polypeptides: methods and reagents for modulating apoptosis
#3023Compositions and methods for cancer diagnosis and treatment
#3024Novel compositions and methods in cancer
#3025OCL-2A3 compositions and uses thereof
#3026Method to control tumor progression and invasiveness
#3027Molecular determinants of myeloma bone disease and use thereof
#3028Mammalian IAP gene family, primers, probes and detection methods
#3029Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
#3030Gene expression profiles and methods of use
#3031Diagnosis and treatment of cervical cancer
#3032Snail, a new marker for tumour invasion and target protein of new antitumoral compounds
#3033Methods and compositions for treating diseases targeting MABA1
#3034Expression vector encoding apoptosis-specific eIF-5A
#3035Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma
#3036Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
#3037Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
#3038Novel compositions and methods for lymphoma and leukemia
#3039Novel genes and markers associated to type 2 diabetes mellitus
#3040Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
#3041Gene screen
#3042Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
#3043Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep1 (prostaglandin e2 ep1)
#3044Method for diagnosing hepatocellular carcinomas
#3045Tumor suppressor designated TS10Q23.3
#3046Methods of diagnosing and treating inflammatory diseases using pac-1 (dusp2)
#3047Snail, a new marker for tumour invasion and target protein of new antitumoral compounds
#3048Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease
#3049Methods of diagnosis and prognosis of ovarian cancer
#3050Snail, a new marker for tumour invasion and target protein of new antitumoral compounds
#3051Micrornas and uses thereof
#3052Tumor suppressor designated TS10q23.3
#3053Methods for assessing and treating leukemia
#3054Mammalian IAP gene family, primers, probes and detection methods
#3055Polymorphism in the macrophage migration inhibitory factor (MIF) gene as marker for prostate cancer
#3056Epidermal growth factor receptor mutations
#3057Use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases
#3058Mammalian IAP gene family, primers, probes and detection methods
#3059Novel nucleic acids and polypeptides
#3060Novel compositions and methods in cancer
#3061Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
#3062WISP polypeptides and nucleic acids encoding same
#3063Computer systems and methods for inferring casuality from cellular constituent abundance data
#3064Method for predicting the response to a treatment
#3065Gene overexpressed in cancer
#3066Allelic variation in the serotonin transporter (SERT) as an indicator of autism
#3067Socs-3 promoter methylation in cancer
#3068Tyrosine kinome
#3069Endogenous retrovirus polypeptides linked to oncogenic transformation
#3070Compositions and methods for cancer
#3071Insulin-induced gene as therapeutic target in diabetes
#3072Mammalian IAP gene family, primers, probes and detection methods
#3073Mammalian IAP gene family, primers, probes and detection methods
#3074COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#3075A141S and G399S mutation in the Omi/HtrA2 protein in Parkinson's disease
#3076Polyvalent cation-sensing receptor in atlantic salmon
#3077Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
#3078Diagnosis of advanced cancer
#3079Method for examining obesity or leanness
#3080Simultaneous quantification of nucleic acids in diseased cells
#3081Methods and compositions for treating diseases targeting CDCP1
#3082Mammalian IAP gene family, primers, probes and detection methods
#3083Mammalian IAP gene family, primers, probes and detection methods
#3084Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3085Mammalian IAP gene family, primers, probes and detection methods
#3086Nucleic acid and amino acid sequences involved in pain
#3087Materials and methods for colorectal cancer screening, diagnosis and therapy
#3088Protein tyrosine phosphatase-prl-1 a a marker and therapeutic target for pancreatic cancer
#3089Use of biomolecular targets in the treatment and visualization of brain tumors
#3090Oculospanin as a tumor specific antigen and methods and compositions utilizing same
#3091Interleukin-8 homologous polypeptides and therapeutic uses thereof
#3092Imaging, diagnosis and treatment of disease
#3093Universal gene chip for high throughput chemogenomic analysis
#3094Methods and compositions for detecting cancers
#3095Inhibition of Lysyl oxidase for treating tumor growth and diagnostics relating thereto
#3096Differentially expressed genes in large granular lymphocyte leukemia
#3097Expression profiles of peripheral blood mononuclear cells for inflammatory bowel diseases
#3098Methods for treatment of age-related macular degeneration
#3099Use of ID4 for diagnosis and treatment of cancer
#3100Mrp3 genes and uses thereof
#3101Prefoldin 4 in the treatment and diagnosis of cancer
#3102621 human secreted proteins
#3103Method for identifying an intestinal phenotype
#3104Use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferative diseases
#3105Differentially expressed nucleic acids that correlate with ksp expression
#3106Prlz regulatory elements in the treatment of disease and the discovery of therapeutics
#3107Gene expression profiles in breast tissue
#3108Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
#3109Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
#3110Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
#3111Gene products differentially expressed in cancerous cells
#3112Mammalian IAP gene family, primers, probes, and detection methods
#3113Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema
#3114Methods and compositions for prenatal diagnosis of mental retardation
#3115Compositions, splice variants and methods relating to breast specific genes and proteins
#3116Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor
#3117Method and means for treatment of osteoarthritis
#3118PAK 2: modulators of lymphocyte activation
#3119Tumor angiogenesis inhibitor alpha 1-antitrypsin
#3120Methods for selecting medications
#3121Viral and viral associated miRNAs and uses thereof
#3122Mechanism for identifying drugs for the treatment of type II diabetes
#3123Murine genomic polynucleotide sequence encoding a G-protein coupled receptor and methods of use therefor
#3124Human podocalyxin alternative-spliced forms and uses thereof
#3125Human dickkopf-related protein and nucleic acid molecules and uses therefor
#3126Identification of 5HT2A receptor ligands by selective amplification of cells transfected with receptors
#3127Cell-type-specific patterns of gene expression
#3128L-SIGN polymorphisms and methods involving use of same
#3129Identification of ligands by selective amplification of cells transfected with receptors
#3130Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus
#3131Compositions and methods for the regulation of cell proliferation and apoptosis
#3132MCL-1 quadruplex nucleic acids and uses thereof
#3133ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
#3134Methods for the identification, assessment, and treatment of patients with cancer therapy
#3135Telomerase promoters sequences for screening telomerase modulators
#3136Genes regulated in ovarian cancer a s prognostic and therapeutic targets
#3137Method of diagnosing colon and gastric cancers
#3138METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS
#3139Methods for identifying drug pharmacology and toxicology
#3140Methods of treatment and diagnosis of kaposi's sarcoma (ks) and ks related diseases
#3141Endogenous retrovirus up-regulated in prostate cancer
#3142Pygopus in diagnosis and treatment of cancer
#3143Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic
#3144Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient
#3145Scroll compressor
#3146Genes and polypeptides relating to human pancreatic cancers
#3147Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
#3148Methods and compositions for assessment of pulmonary function and disorders
#3149Methods of diagnosis and prognosis of pancreatic cancer
#3150Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors
#3151Methods of reducing microbial resistance to drugs
#3152Mild osteoarthritis biomarkers and uses thereof
#3153Methods for predicting late onset Alzheimer disease in an individual
#3154Antibodies to PRO1561 polypeptide
#3155Genetic polymorphisms associated with myocardial infarction and uses thereof
#3156Compositions and methods for diagnosing and treating neuropsychiatric disorders
#3157Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3158TRPC6 involved in glomerulonephritis
#3159Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone
#3160Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)
#3161Predicting treatment response in cancer subjects
#3162Method for diagnosing myocardial infarction
#3163Bcl2L12 polypeptide activators and inhibitors
#3164Method for screening molecules that restore NOD1 activity in cells containing an NOD2 mutation that reduces or eliminates NOD1 activity
#3165Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3166Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3167Gene families associated with liver cancer
#3168Computer systems and methods for inferring causality from cellullar constituent abundance data
#3169Cancer genes
#3170Methods for characterizing agonists and partial agonists of target molecules
#3171Method of analyzing breast cancer susceptibility and resistance
#3172Gene expression profiles and methods of use
#3173Genes and polypeptides relating to myeloid leukemia
#3174Canine gene microarrays
#3175Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
#3176Methods for the treatment of insulin resistance and disease states characterized by insulin resistance
#3177METHODS FOR THE DIAGNOSIS AND TREATMENT OF METASTATIC PROSTATE TUMORS
#3178Biomarkers for predicting prostate cancer progression
#3179Methods of screening and compositions for life span modulators
#3180Novel assays for assessing cancerous cell growth
#3181Gene products differentially expressed in cancerous cells
#3182Methods for identifying therapeutic targets involved in glucose and lipid metabolism
#3183Modulation of insulin like growth factor I receptor expression
#3184Association of snps in the comt locus and neighboring loci with schizophrenia, bipolar disorder, breast cancer and colorectal cancer
#3185K203 gene and protein
#3186Novel therapeutic targets in cancer
#3187Cancer-linked gene as target for chemotherapy
#31887a5/prognostin and use thereof for the diagnostic and therapy of tumors
#3189Imaging and selective retention of phospholipid ether analogs
#3190Method of screening for inhibitors of human Fatty Acid-CoA Ligase 4
#3191Methods and compositions for modulating Necdin function
#3192Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
#3193Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseases
#3194Methods for detecting endocrine cancer
#3195Oncogene, recombinant protein derived therefrom, and uses thereof
#3196Eubacterial tmRNA sequences and uses thereof
#3197Proteins associated with cell growth, differentiation, and death
#3198Polynucleotides and polypeptides of the erythropoietin gene
#3199Methods for assessing emphysema
#3200Novel compositions and methods for cancer
#3201Beta-parvin expression for use in diagnostic methods for assessment of breast cancer
#3202Interleukin-8 homologous polypeptides and therapeutic uses thereof
#3203Method for treating or preventing metastasis of colorectal cancers
#3204Mammalian IAP gene family, primers, probes and detection methods
#3205Novel compositions and methods for cancer
#3206Markers for cyclin dependent kinase inhibitors
#3207Methods for identifying risk of breast cancer and treatments thereof
#3208Method for diagnosing diffuse-type gastric cancers
#3209miR-155 assay
#3210Method for diagnosis of colorectal tumors
#3211Method of evaluating compound efficacious in treating obesity by using slc25a10
#3212Antibodies to PRO1275 polypeptide
#3213Novel therapeutic targets in cancer
#3214HLJ1 gene expression
#3215Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3216Therapeutic targets in cancer
#3217Method for diagnosing testicular seminomas
#3218Mammalian tumor susceptibility genes and their uses
#3219Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative disease
#3220Nucleic acid sequences and methods for identifying compounds that affect RNA/RNA binding protein interactions and mRNA functionality
#3221Use of differentially expressed nucleic acid sequences as biomarkers for cancer
#3222Gene expression profiles in stomach cancer
#3223Fanc gene mutations in cancer
#3224Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers
#3225Nucleic acid sequences differentially expressed in cancer tissue
#3226Modulation of growth hormone receptor expression and insulin-like growth factor expression
#3227Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
#3228Novel compositions and methods in cancer associated with altered expression of MCM3AP
#3229Antidepressant drug target
#3230Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
#3231Use of neuronal apoptosis inhibitor protein (NAIP)
#3232Gene families associated with cancers
#3233Anti-pro1477 antibodies
#3234Use of sFRPs as markers of BMP activity
#3235Markers of pre-term labor
#3236Breast specific protein expressed in cancer and methods of use thereof
#3237Diagnosis and treatment of cancer
#3238Genes and polypeptides relating to prostate cancers
#3239Methods for the treatment, diagnosis, and prognosis of cancer
#3240Modulation of glucocorticoid receptor expression
#3241Methods of screening for compounds that improve engraftment
#3242Composition splice variants and methods relating to cancer specific genes and proteins
#3243Diagnosis and therapy of cancer using SGP28-related molecules
#3244Reagents and methods useful for detecting diseases of the breast
#3245Novel compositions and methods in cancer
#3246Differential gene expression in schizophrenia
#3247Genes related to drug resistance
#3248Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
#3249AMPK pathway components
#3250Methods of screening for modulators of nerve growth factor
#3251Amplified and overexpressed gene in colorectal cancers
#3252Novel diagnostic and therapeutic methods and reagents therefor
#3253Use of resveratrol to regulate expression of apolipoprotein A1
#3254Kinases and uses thereof
#3255Molecular technologies for improved risk classification and therapy for acute lymphoblastic leukemia in children and adults
#3256MyD88 as a therapeutic target for cancer
#3257Erk7 and erk8, novel diagnostic markers for cancer
#3258Assay for detection of renal cell carcinoma
#3259Gene products differentially expressed in cancerous breast cells and their methods of use
#3260Methods for treating patients and identifying therapeutics
#3261Prediction of Parkinson's disease using gene expression levels of peripheral blood samples
#3262Treatment of cancer and compositions
#3263Differential expression of genes in microsatellite instability
#3264Novel compositions and methods in cancer
#3265Amplified cancer target genes useful in diagnosis and thereapeutic screening
#3266Preventives/remedies for cancer
#3267G protein coupled receptors and uses thereof
#3268Directed differentiation of embryonic stem cells into an endoderm cell
#3269Mammalian IAP gene family, primers, probes, and detection methods
#3270Compositions and methods relating to cell adhesion molecule L1
#3271Cancer associated plexin B1 mutations
#3272Brain endothelial cell expression patterns
#3273Materials and methods for treating cancer
#3274Protein associated with cell growth, differentiation, and death
#3275Antibody against tumor specific antigen as target
#3276Paks as modifiers of the chk pathway and methods of use
#3277Use of murine genomic regions identified to be involved in tumor developement for the development of anti-cancer drugs and diagnosis of cancer
#3278Gene families associated with stomach cancer
#3279Compositions and methods in cancer associated with altered expression of KCNJ9
#3280Prostate specific genes and the use thereof as targets for prostate cancer therapy
#3281Preventives/remedies for neurodegenerative diseases
#3282Method for treating or preventing metastasis of colorectal cancers
#3283Porcine reproductive and respiratory syndrome virus receptor components and uses thereof
#3284Biomarkers for prostate cancer metastasis
#3285Methods to diagnose and treat lung cancer
#3286Use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity
#3287Method for diagnosis of intestinal-type gastric tumors
#3288Gene panel participating in liver regeneration
#3289Prophylactic/therapeutic agent for cancer
#3290Methods of screening agents for activity using teleosts
#3291Rors as modifiers of the p21 pathway and methods of use
#3292Method for diagnosing inflammatory bowel disease
#3293Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
#3294PCA3, PCA3 genes, and methods of use
#329512 human secreted proteins
#3296Method and kit for detecting a risk of acute myocardial infarction
#3297Role of Glycogen Synthase Kinase-3 and tetraspanins in ethanol-induced henaviors
#3298Eef1a2 for use in the prognosis, diagnosis, and treatment of cancer
#3299Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases
#3300Cancer-linked gene as target for chemotherapy